StonvexLoading…
StonvexStonvexStonvexCore line items from TSLA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $94.83B | $97.69B | $96.77B | $81.46B |
Operating Income | $4.36B | $7.08B | $8.89B | $13.66B |
Net Income | $3.79B | $7.09B | $15.00B | $12.56B |
EPS (Diluted) | $1.08 | $2.04 | $4.30 | $3.62 |
Total Assets | $137.81B | $122.07B | $106.62B | $82.34B |
Total Liabilities | $54.94B | $48.39B | $43.01B | $36.44B |
Cash & Equivalents | $16.51B | $16.14B | $16.40B | $16.25B |
Free Cash Flow OCF − CapEx | $6.22B | $3.58B | $4.36B | $7.57B |
Shares Outstanding | 3.75B | 3.22B | 3.19B | 3.16B |